ROIV - Roivant unit appoints Vincent Hennemand as CEO
2023-10-13 08:10:01 ET
More on Roivant Sciences
- Skin In The Game: Behind Roivant's Significant Rise
- Immunovant to raise $450M from public offering and private placement
- Immunovant stock rallies for second day, fueled by public offering, drug data
For further details see:
Roivant unit appoints Vincent Hennemand as CEO